New heart valve tested for patients too frail for open surgery
NCT ID NCT04982588
Summary
This study is testing a new type of replacement heart valve for people in China with severe, symptomatic aortic stenosis who are at high risk for traditional open-heart surgery. The valve is implanted using a less invasive procedure called TAVR. Researchers will track how safe the valve is and how well it works over five years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE SYMPTOMATIC AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, 100000, China
-
Chinese PLA General Hospital, Chinese PLA Medical School
Beijing, Beijing Municipality, 100000, China
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 610000, China
Conditions
Explore the condition pages connected to this study.